Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020
- PMID: 32555134
- PMCID: PMC7302472
- DOI: 10.15585/mmwr.mm6924e2
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020
Abstract
The coronavirus disease 2019 (COVID-19) pandemic resulted in 5,817,385 reported cases and 362,705 deaths worldwide through May, 30, 2020,† including 1,761,503 aggregated reported cases and 103,700 deaths in the United States.§ Previous analyses during February-early April 2020 indicated that age ≥65 years and underlying health conditions were associated with a higher risk for severe outcomes, which were less common among children aged <18 years (1-3). This report describes demographic characteristics, underlying health conditions, symptoms, and outcomes among 1,320,488 laboratory-confirmed COVID-19 cases individually reported to CDC during January 22-May 30, 2020. Cumulative incidence, 403.6 cases per 100,000 persons,¶ was similar among males (401.1) and females (406.0) and highest among persons aged ≥80 years (902.0). Among 599,636 (45%) cases with known information, 33% of persons were Hispanic or Latino of any race (Hispanic), 22% were non-Hispanic black (black), and 1.3% were non-Hispanic American Indian or Alaska Native (AI/AN). Among 287,320 (22%) cases with sufficient data on underlying health conditions, the most common were cardiovascular disease (32%), diabetes (30%), and chronic lung disease (18%). Overall, 184,673 (14%) patients were hospitalized, 29,837 (2%) were admitted to an intensive care unit (ICU), and 71,116 (5%) died. Hospitalizations were six times higher among patients with a reported underlying condition (45.4%) than those without reported underlying conditions (7.6%). Deaths were 12 times higher among patients with reported underlying conditions (19.5%) compared with those without reported underlying conditions (1.6%). The COVID-19 pandemic continues to be severe, particularly in certain population groups. These preliminary findings underscore the need to build on current efforts to collect and analyze case data, especially among those with underlying health conditions. These data are used to monitor trends in COVID-19 illness, identify and respond to localized incidence increase, and inform policies and practices designed to reduce transmission in the United States.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures
Similar articles
-
Update: Characteristics of Health Care Personnel with COVID-19 - United States, February 12-July 16, 2020.MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1364-1368. doi: 10.15585/mmwr.mm6938a3. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32970661 Free PMC article.
-
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32240123 Free PMC article.
-
COVID-19 Among American Indian and Alaska Native Persons - 23 States, January 31-July 3, 2020.MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1166-1169. doi: 10.15585/mmwr.mm6934e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32853193 Free PMC article.
-
Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 - United States, May-August 2020.MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1517-1521. doi: 10.15585/mmwr.mm6942e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33090984 Free PMC article.
-
SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020.MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1324-1329. doi: 10.15585/mmwr.mm6937e4. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32941417
Cited by
-
Analyzing prognosis and comparing predictive scoring systems for mortality of COVID-19 patients with liver cirrhosis: a multicenter retrospective study.BMC Infect Dis. 2024 Nov 18;24(1):1315. doi: 10.1186/s12879-024-10223-4. BMC Infect Dis. 2024. PMID: 39558236 Free PMC article.
-
The Effectiveness and Safety of Remdesivir Use in COVID-19 Patients with Neutropenia: A Retrospective Cohort Study.Life (Basel). 2024 Oct 1;14(10):1252. doi: 10.3390/life14101252. Life (Basel). 2024. PMID: 39459552 Free PMC article.
-
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Patient Undergoing Dialysis and Having Cardiopulmonary Failure Due to Coronavirus Disease: A Case Report.Cureus. 2024 Sep 13;16(9):e69317. doi: 10.7759/cureus.69317. eCollection 2024 Sep. Cureus. 2024. PMID: 39416545 Free PMC article.
-
The SpO2/FiO2 Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients.J Clin Med. 2024 Oct 2;13(19):5884. doi: 10.3390/jcm13195884. J Clin Med. 2024. PMID: 39407943 Free PMC article.
-
Prolonged course of Paxlovid administration in a centenarian with COVID-19: A case report.World J Radiol. 2024 Sep 28;16(9):489-496. doi: 10.4329/wjr.v16.i9.489. World J Radiol. 2024. PMID: 39355387 Free PMC article.
References
-
- Chow N, Fleming-Dutra K, Gierke R, et al.; CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382–6. 10.15585/mmwr.mm6913e2 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
